About Impact Proteomics
Impact Proteomics is a private company based in Pittsburgh, Pennsylvania. It has reported $250,000 raised in two offerings on Form D since February 2020. Its chief executive is Jeffrey Whitmore.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Aug 6, 2024 | Aug 14, 2024 | $50,000of $1.0M target | 1 | $50,000 | OptionsRule 506(b) | Form D ↗ |
| Feb 7, 2020 | Feb 21, 2020 | $200,000of $300K target | 2 | $100K | Debt, Options, Securities on exerciseRule 506(b) | Form D ↗ |
| Total, two offerings | $250,000 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Impact Proteomics's Form D filed Aug 14, 2024.
JM
Jonathan Minden
Executive officer, director and promoter
JW
Jeffrey Whitmore
CEO and director
Earlier filings also listed Amber Lucas (ceo and director, last listed Feb 2020).